Interesting study on Pioglitazone significantly improving vascular stiffness and cardiometabolic parameters vs. PBO in #lupus by @sarfarazhasni et al. Pioglitazone: potential tx option to reduce CV risk in SLE?🧐 @RheumNow #ACR21 abs1748 https://t.co/ow3zA2hhnx